Recent trends in pediatric Haemophilus influenzae type B infections in Canada

CMAJ. Canadian Medical Association Journal

Volumn 154, Issue 7, 1996, Pages 1041-1047

  Scheifele, Aavid W ^a   Jadavji, Tajdin P ^b   Law, Barbara J ^c   Gold, Ronald ^d   MacDonald, Noni E ^e   Lebel, Marc H ^f   Mills, Elaine L ^g   Déry, Pierre ^h   Halperin, Scott A ⁱ   Morris, Rocert F ^j   Marchessault, Victor ^k   Duclos, Philippe J ^l  

^a BC CHILDREN S HOSPITAL   (Canada)

^b Department of Pediatrics   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^f UNIVERSITY OF MONTREAL   (Canada)

^g MONTREAL CHILDREN S HOSPITAL   (Canada)

^h LAVAL UNIVERSITY   (Canada)

ⁱ Izaak Walton Killam Hospital for Children   (Canada)

^j Dept Biochem Ped   (Canada)

^k CANADIAN PAEDIATRIC SOCIETY   (Canada)

^l LAB CENTRE FOR DISEASE CONTROL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; CANADA; CHILDHOOD DISEASE; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORTALITY; PRESCHOOL CHILD; VACCINATION;

EID: 0343905624     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Klein JO, Feigin RD, McCracken GH: Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics 1986; 78 (suppl): 959-982
2. Janai H, Stutman HR, Marks MI: Invasive Haemophilus influenzae type b infections: a continuing challenge. Am J Infect Control 1990; 18: 160-166
3. Haemophilus influenzae infection in Canada, 1969-1985 Can Dis Wkly Rep 1986; 12: 37-43
4. Broome CV: Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J 1987; 6: 779-782
5. Jadavji T, Biggar WD, Gold R et al: Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics 1986; 78: 21-25
6. Statement on Haemophilus b polysaccharide vaccine. Can Dis Wkly Rep 1986; 12: 33-35
7. Statement on Haemophilus b conjugate vaccine. Can Dis Wkly Rep 1988; 14: 37-40
8. Greenberg DP, Vadheim CM, Bordenave N et al: Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older. JAMA 1991; 265: 987-992
9. Wenger JD, Pierce R, Deaver KA et al: Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Lancet 1991; 338: 395-398
10. Fisk R, Farley J, Angel L: Haemophilus influenzae disease trends to 1990, British Columbia. Dis Surveillance 1991; 12: 174-177
11. Naus M, Watley R: Impact of Hib vaccine on Haemophilus influenzae type b disease in Ontario. Public Health Epidemiol Rep Out (PHERO) 1993; 4: 165-169
12. Barbour M, Mayon-White RT, Coles C et al: The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995; 171: 93-98
13. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. Can Commun Dis Rep 1992; 18; 169-176
14. Murphy TV, White KE, Pastor P et al: Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA 1993; 269: 246-248
15. Adams WG, Deaver JA, Cochi SL et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269: 221-226
16. Schoendorf KC, Adams WC, Kiely JL et al: National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics 1994; 93: 663-668
17. Morris R, Halperin S, Déry P et al: IMPACT monitoring network: a better mousetrap. Can J Infect Dis 1993; 4: 194-195
18. International Classification of Diseases, 9th Revision (Clinical Modification), 4th ed (publ no DHHS [PHS] 91-1260), US Department of Health and Human Services, Washington, 1991
19. Scheifele DW, Bjornson G, Arcand T et al: Antigenuria after receipt of Haemophilus b diphtheria toxoid conjugate vaccine. Pediatr Infect Dis J 1989; 8: 887-888
20. Haemophilus b conjugate vaccine failure. Can Commun Dis Rep 1994; 20: 37-39
21. Sherry B, Emanuel I, Kronmal RA et al: Interannual variation in the incidence of Haemophilus influenzae type b meningitis. JAMA 1989; 261: 1924-1929
22. Hay JW, Daum RS: Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at 18 months of age. Pediatr Infect Dis J 1990; 9: 246-252
23. Standaert SM, Lefkowitz LB, Horan JM et al: The reporting of communicable diseases: a controlled study of Neisseria meningitidis and Haemophilus influenzae infections. Clin Infect Dis 1995; 20: 30-36
24. Vadheim CM, Greenberg DP, Eriksen E et al: Protection provided by Haemophilus influenzae type b conjugate vaccines in Los Angeles County: a case-control study. Pediatr Infect Dis J 1994; 13: 274-280
25. Holmes S, Granoff DM: The biology of Haemophilus influenzae type b failure. J Infect Dis 1992; 165 (suppl): S121-S12